Recomendados
Recomendados
Mais conteúdo relacionado
Mais de Rose088
Mais de Rose088 (20)
Último
Último (20)
Malignant mesothelioma – pipeline review, h2 2012
- 1. Malignant Mesothelioma – Pipeline Review, H2 2012 Aarkstore.com announces, The Latest market research report is available in its vast collection: Malignant Mesothelioma – Pipeline Review, H2 2012 RSS link of Global Markets Direct Summary Global Markets Direct’s, Malignant Mesothelioma - Pipeline Review, H2 2012, provides an overview of the Malignant Mesothelioma therapeutic pipeline. This report provides information on the therapeutic development for Malignant Mesothelioma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Malignant Mesothelioma. Malignant Mesothelioma - Pipeline Review, H2 2012 is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - A snapshot of the global therapeutic scenario for Malignant Mesothelioma. - A review of the Malignant Mesothelioma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined
- 2. Malignant Mesothelioma – Pipeline Review, H2 2012 therapeutics. Table of contents: List of Tables 5 List of Figures 6 Introduction 8 Global Markets Direct Report Coverage 8 Malignant Mesothelioma Overview 9 Therapeutics Development 10 An Overview of Pipeline Products for Malignant Mesothelioma 10 Malignant Mesothelioma Therapeutics under Development by Companies 12 Malignant Mesothelioma Therapeutics under Investigation by Universities/Institutes 15 Late Stage Products 19 Comparative Analysis 19 Mid Clinical Stage Products 20 Comparative Analysis 20 Early Clinical Stage Products 21 Comparative Analysis 21 Discovery and Pre-Clinical Stage Products 22 Comparative Analysis 22 Malignant Mesothelioma Therapeutics – Products under Development by Companies 23 Malignant Mesothelioma Therapeutics – Products under Investigation by Universities/Institutes 24 Companies Involved in Malignant Mesothelioma Therapeutics Development 30 Viralytics Ltd. 30 Merck & Co., Inc. 31 Oxford BioMedica plc 32 Plexxikon Inc. 33 Pfizer Inc. 34 Aduro BioTech 35 Aeolus Pharmaceuticals, Inc. 36 AEterna Zentaris Inc. 37 Bionomics Limited 38
- 3. Malignant Mesothelioma – Pipeline Review, H2 2012 Morphotek, Inc. 39 CanBas Co., Ltd. 40 MolMed S.p.A. 41 Ys Therapeutics Co., Ltd. 42 List of Figures List of Tables are also include. For more related Reports Plz follow The link: Pipeline Review, H2 2012 http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2 2012&PubId=&pagenum=1 Myocardial Infarction – Pipeline Review, H2 2012 Metastatic Liver Cancer – Pipeline Review, H2 2012 Mantle Cell Lymphoma – Pipeline Review, H2 2012 Malignant Mesothelioma – Pipeline Review, H2 2012 Rectal Cancer – Pipeline Review, H2 2012 Chemotherapy Effects – Pipeline Review, H2 2012 Follicular Lymphoma – Pipeline Review, H2 2012
- 4. Malignant Mesothelioma – Pipeline Review, H2 2012 Sleep Disorders – Pipeline Review, H2 2012 Neuroblastoma – Pipeline Review, H2 2012 Cytomegalovirus (HHV-5) Infections – Pipeline Review, H2 2012 Search More Reports Related to This Category : Pharmaceuticals and Healthcare http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1 For More details Plz do contact : Aarkstore Enterprise Lavanya Phone:08149852585 Email: enquiry@aarkstore.com